This is a Validated Antibody Database (VAD) review about human Ets1, based on 13 published articles (read how Labome selects the articles), using Ets1 antibody in all methods. It is aimed to help Labome visitors find the most suited Ets1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ets1 synonym: ETS-1; EWSR2; c-ets-1; p54; protein C-ets-1; Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1; v-ets avian erythroblastosis virus E2 oncogene homolog 1; v-ets avian erythroblastosis virus E26 oncogene homolog 1
Abcam
rabbit polyclonal |
| Abcam Ets1 antibody (Abcam, ab124282) was used in western blot on human samples at 1:500 (fig 2d). PLoS ONE (2017) ncbi |
rabbit polyclonal |
| Abcam Ets1 antibody (Abcam, ab26096) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi |
rabbit polyclonal |
| Abcam Ets1 antibody (Abcam, ab59179) was used in western blot on human samples (fig 5g). Cell Commun Signal (2015) ncbi |
rabbit polyclonal |
| Abcam Ets1 antibody (Abcam, ab26096) was used in western blot on human samples at 1:1000. Oncol Rep (2015) ncbi |
rabbit polyclonal |
| Abcam Ets1 antibody (Abcam, ab26096) was used in immunohistochemistry - paraffin section on human samples at 1:250 and in western blot on human samples at 1:1000. J Virol (2013) ncbi |
Invitrogen
mouse monoclonal (8A8) |
| In order to evaluate the mechanisms by which memory T cells exhibit transcriptional memory, Invitrogen Ets1 antibody (Thermo Fisher, 8A8) was used in flow cytometry on human samples at 1:100 (fig 5a). Sci Rep (2017) ncbi |
rabbit polyclonal |
| In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Invitrogen Ets1 antibody (Invitrogen, 44-1109) was used in western blot on human samples . Cancer Cell (2014) ncbi |
rabbit polyclonal |
| In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Invitrogen Ets1 antibody (Invitrogen, 44-1111) was used in western blot on human samples . Cancer Cell (2014) ncbi |
Bethyl
rabbit polyclonal |
| Bethyl Ets1 antibody (Bethyl Laboratories, A303-501A) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi |
rabbit polyclonal |
| In order to characterize the molecular identity of uterine carcinosarcomas., Bethyl Ets1 antibody (BethYl, A303-501A) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi |
rabbit polyclonal |
| In order to describe the features of 228 primary cervical cancers, Bethyl Ets1 antibody (Bethyl Laboratories, A303-501A) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi |
rabbit polyclonal |
| In order to study how phosphorylation alters COP1-binding sites of oncoproteins, Bethyl Ets1 antibody (Bethyl, A303-501A) was used in western blot on human samples . Cancer Cell (2014) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (C-4) |
| Santa Cruz Biotechnology Ets1 antibody (Santa Cruz, sc55581X) was used in EMSA on mouse samples (fig 2). PLoS ONE (2016) ncbi |
mouse monoclonal (C-4) |
| Santa Cruz Biotechnology Ets1 antibody (Santa Cruz, sc-55581) was used in chromatin immunoprecipitation on human samples (fig 3g). Oncotarget (2015) ncbi |
Abnova
rabbit polyclonal |
| In order to evaluate the regulation of Epstein-Barr virus-infected ARPE19 cell migration as a model of choroidal neovascularization, Abnova Ets1 antibody (Abnova, PAB24790) was used in western blot on human samples at 1:500 (fig 1c). Exp Ther Med (2017) ncbi |
Articles Reviewed
- Li C, Wu S, Wang H, Bi X, Yang Z, Du Y, et al. The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer. Oncotarget. 2015;6:19542-51 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments